These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15621821)

  • 1. Mathematical models of cancer dormancy.
    Page K; Uhr JW
    Leuk Lymphoma; 2005 Mar; 46(3):313-27. PubMed ID: 15621821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer dormancy: lessons from a B cell lymphoma and adenocarcinoma of the prostate.
    Rabinovsky R; Uhr JW; Vitetta ES; Yefenof E
    Adv Cancer Res; 2007; 97():189-202. PubMed ID: 17419946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice.
    Racila E; Scheuermann RH; Picker LJ; Yefenof E; Tucker T; Chang W; Marches R; Street NE; Vitetta ES; Uhr JW
    J Exp Med; 1995 Apr; 181(4):1539-50. PubMed ID: 7535341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of vaccination with idiotypic protein or DNA, (+/-IL-2), the depletion of regulatory T cells, or the blockade of CTLA-4 to prolong dormancy in mice with BCL1 lymphoma.
    Pop LM; Smallshaw JE; Tucker TF; Stevenson FK; Vitetta ES
    J Immunother; 2005; 28(6):525-34. PubMed ID: 16224269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-cell vaccination induces tumor dormancy in a murine model of B-cell leukemia/lymphoma (BCL1).
    Morecki S; Pugatsch T; Levi S; Moshel Y; Slavin S
    Int J Cancer; 1996 Jan; 65(2):204-8. PubMed ID: 8567118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor dormancy and cell signaling. V. Regrowth of the BCL1 tumor after dormancy is established.
    Vitetta ES; Tucker TF; Racila E; Huang YW; Marches R; Lane N; Scheuermann RH; Street NE; Watanabe T; Uhr JW
    Blood; 1997 Jun; 89(12):4425-36. PubMed ID: 9192767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiotype vaccination strategies against a murine B-cell lymphoma: dendritic cells loaded with idiotype and bispecific idiotype x anti-class II antibodies can protect against tumor growth.
    Bohlen H; Thielemanns K; Tesch H; Engert A; Wolf HJ; van Camp B; Urbain J; Diehl V
    Cytokines Mol Ther; 1996 Dec; 2(4):231-8. PubMed ID: 9384709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer dormancy. VII. A regulatory role for CD8+ T cells and IFN-gamma in establishing and maintaining the tumor-dormant state.
    Farrar JD; Katz KH; Windsor J; Thrush G; Scheuermann RH; Uhr JW; Street NE
    J Immunol; 1999 Mar; 162(5):2842-9. PubMed ID: 10072532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour dormancy and cell signalling--III: Role of hypercrosslinking of IgM and CD40 on the induction of cell cycle arrest and apoptosis in B lymphoma cells.
    Marches R; Racila E; Tucker TF; Picker L; Mongini P; Hsueh R; Vitetta ES; Scheuermann RH; Uhr JW
    Ther Immunol; 1995 Jun; 2(3):125-36. PubMed ID: 8885131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of B cell tumor dormancy by anti-idiotypic antibodies.
    Yefenof E; Picker LJ; Scheuermann RH; Vitetta ES; Street NE; Tucker TF; Uhr JW
    Curr Opin Immunol; 1993 Oct; 5(5):740-4. PubMed ID: 8240736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Regulatory B Cell-Like Malignant Cells and Treg Cells in the Mouse Model of BCL1 Tumor Dormancy.
    BitMansour A; Pop LM; Vitetta ES
    PLoS One; 2016; 11(12):e0167618. PubMed ID: 27959896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer dormancy: studies of the murine BCL1 lymphoma.
    Uhr JW; Tucker T; May RD; Siu H; Vitetta ES
    Cancer Res; 1991 Sep; 51(18 Suppl):5045s-5053s. PubMed ID: 1884380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dormancy in a model of murine B cell lymphoma.
    Uhr JW; Marches R
    Semin Cancer Biol; 2001 Aug; 11(4):277-83. PubMed ID: 11513563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer dormancy: isolation and characterization of dormant lymphoma cells.
    Yefenof E; Picker LJ; Scheuermann RH; Tucker TF; Vitetta ES; Uhr JW
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1829-33. PubMed ID: 8446596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor dormancy and cancer stem cells: two sides of the same coin?
    Kleffel S; Schatton T
    Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of T-cell subsets in the bispecific antibody (anti-idiotype x anti-CD3) treatment of the BCL1 lymphoma.
    Demanet C; Brissinck J; Leo O; Moser M; Thielemans K
    Cancer Res; 1994 Jun; 54(11):2973-8. PubMed ID: 8187084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor dormancy: long-term survival in a hostile environment.
    Quesnel B
    Adv Exp Med Biol; 2013; 734():181-200. PubMed ID: 23143980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor dormancy and immunoescape.
    Quesnel B
    APMIS; 2008; 116(7-8):685-94. PubMed ID: 18834412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL.
    Yi AK; Hornbeck P; Lafrenz DE; Krieg AM
    J Immunol; 1996 Dec; 157(11):4918-25. PubMed ID: 8943396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo retargeting of T cell effector function by recombinant bispecific single chain Fv (anti-CD3 x anti-idiotype) induces long-term survival in the murine BCL1 lymphoma model.
    De Jonge J; Heirman C; de Veerman M; Van Meirvenne S; Moser M; Leo O; Thielemans K
    J Immunol; 1998 Aug; 161(3):1454-61. PubMed ID: 9686611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.